Incyte Corporation (INCY) by event type

INCY moves most on analyst downgrades — a median of -0.64% at 30 minutes across 33 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the INCY overview →

By event type

How INCY reacts across 6 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
1,150 of 2,717
36+0.07%64%+0.23%
Analyst downgrades
2,300 of 2,603
33-0.64%30%-0.30%
Coverage initiations
671 of 2,283
27+0.24%52%-0.06%
Rating reiterations
2,110 of 3,522
185-0.03%48%+0.11%
Price-target raises
1,409 of 1,790
47-0.12%40%-0.24%
Price-target cuts
192 of 1,527
21+0.21%62%+0.33%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.

That’s how INCY usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · INCY overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
Novan, Inc. (NOVN)634-0.02%45%
Zimmer Biomet Holdings, Inc. (ZBH)634+0.11%59%
BIOSPECIFICS TECHNOLOGIES (BSTC)6320.00%43%
Danaher Corporation (DHR)632+0.04%52%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.